Luigi Mangione's defense team abruptly withdrew its psychiatric defense strategy Thursday, one day after announcing it — and the reversal tells ordinary Americans plenty about how legal maneuvering works when the system brings its full weight down on a case.
Mangione's lawyer Karen Friedman Agnifilo submitted a one-sentence letter to Manhattan Judge Gregory Carro withdrawing the defense's notice under New York's psychiatric defense statute. The move came just 24 hours after the same attorneys told the court they planned to argue the 28-year-old was suffering from "extreme emotional disturbance" when UnitedHealthcare CEO Brian Thompson was shot dead Dec. 4, 2024.
The timing matters. Mangione's lawyers faced a Thursday deadline to hand prosecutors medical records documenting whatever "malady" they planned to claim triggered the disturbance. By withdrawing the formal notice, they avoid turning over those records — while preserving the ability to argue extreme emotional disturbance at trial without calling mental health experts or introducing psychiatric evidence.
"They are still perfectly free to pursue the defense of extreme emotional disturbance," veteran defense attorney Ron Kuby told the New York Post. They just can't call experts, show mental health records, or introduce evidence of any psychiatric condition.
If a jury bought the disturbance defense, it would knock a murder charge down to manslaughter — 25 years maximum instead of a potential life sentence. But the physical evidence makes that a steep climb. Judge Carro already ruled admissible a 3D-printed pistol matching the murder weapon and a notebook prosecutors say details plans to "wack the CEO at the annual parasitic bean-counter convention" and "rebel against the deadly, greed fueled health insurance cartel."
Here's where the two-tiered system comes into focus. Mangione faces both state murder charges and federal stalking charges — dual prosecutions that stack potential sentences and, critically, eliminate legal options available in state court. Agnifilo protested Carro's decision to unseal psychiatric defense materials, warning it would be "prejudicial to his defense to the exact same facts" in federal court, where an emotional disturbance defense isn't even permitted. The feds get the advantage of state-court disclosures without offering the same legal avenues in return.
The ammunition in Thompson's killing bore the words "delay," "deny," and "depose" — a reference to insurance industry tactics for avoiding payouts. NBC News noted that Thompson's killing "unleashed a torrent of hostility toward the industry." The Guardian and Baltimore News both repeated this detail but offered no scrutiny of UnitedHealth Group's practices or why Americans might recognize the phrase.
Mangione's state trial is set for Sept. 8; his federal trial begins Oct. 13. He has pleaded not guilty in both.
The legal gamesmanship will dominate headlines. What won't get covered: why a CEO's killing triggers dual state-federal prosecution with maximum pressure, while ordinary Americans who've been bankrupted or denied care by the same industry get no hearing at all.
